Correlation between molybdenum target mammography signs and pathological prognostic factors of breast cancer

Y. Zhang, AD. Ma, HX. Jia

Article ID: 4066
Vol 30, Issue 1, 2016
DOI: https://doi.org/10.54517/jbrha4066
Received: 6 June 2022; Accepted: 6 June 2022; Available online: 6 June 2022; Issue release: 6 June 2022

Abstract

This study explores the correlation between molybdenum target (mo-target) mammography signs and pathological prognostic factors of breast cancer. We selected 320 breast cancer patients who were treated between January 2014 and January 2016; using single-factor and multiple-factor logistic regression method, we made correlation analysis on their clinical features, pathological features and mo-target mammography signs. Among mo-target mammography signs, lumps accompanied with calcification and blurry edge were associated with high histologic grades; lumps accompanied with calcification and clear edge were associated with Ki-67 positive; compared with the patients who had lumps with non-stellate edges, positive rates of estrogen receptor (ER) and progesterone receptor (PR) were significantly higher for the patients who had lumps with stellate edges (p<0.01), while positive rate of human epidermal growth factor receptor-2 (HER-2) and tumor proliferative activity were significantly lower (p<0.05, p<0.01). According to the study, we can conclude that mo-target mammography signs mainly include lumps and calcification. Mo-target mammography can improve the accuracy of diagnosis and reduce misdiagnosis or missed diagnosis. Part of mo-target mammography signs are associated with clinical pathology prognostic factors; by grasping the relation, breast cancer patient conditions are expected to be relieved.


Keywords

breast cancer;pathological prognostic factors;molybdenum target mammography


References

Supporting Agencies



Copyright (c) 2016 Y. Zhang, AD. Ma, HX. Jia




This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).